Advertisement
ELDN vs RLAY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELDN is a StrongBuy and RLAY is a StrongBuy.
ELDN sees its Stochastic Oscillator ascends from oversold territory
On October 22, 2026, the Stochastic Oscillator for ELDN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In 59 of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ELDN's RSI Indicator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Moving Average Convergence Divergence (MACD) for ELDN just turned positive on October 21, 2026. Looking at past instances where ELDN's MACD turned positive, the stock continued to rise in 40 of 46 cases over the following month. The odds of a continued upward trend are 87%.
Following a +2.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELDN advanced for three days, in 222 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
ELDN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELDN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for ELDN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.661) is normal, around the industry mean (2.973). P/E Ratio (-2.556) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. ELDN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
RLAY in +13.33% Uptrend, advancing for three consecutive days on October 20, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RLAY advanced for three days, in 238 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on RLAY as a result. In 76 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for RLAY just turned positive on October 21, 2026. Looking at past instances where RLAY's MACD turned positive, the stock continued to rise in 36 of 42 cases over the following month. The odds of a continued upward trend are 86%.
RLAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
RLAY moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RLAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for RLAY entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.516) is normal, around the industry mean (2.973). P/E Ratio (-11.756) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (333.333) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. RLAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ELDN | RLAY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 11 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 71 Overvalued | 22 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 83 | 37 | |
P/E GROWTH RATING 1..100 | 98 | 35 | |
SEASONALITY SCORE 1..100 | 27 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RLAY's Valuation (22) in the null industry is somewhat better than the same rating for ELDN (71) in the Pharmaceuticals Major industry. This means that RLAY’s stock grew somewhat faster than ELDN’s over the last 12 months.
RLAY's Profit vs Risk Rating (100) in the null industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that RLAY’s stock grew similarly to ELDN’s over the last 12 months.
RLAY's SMR Rating (97) in the null industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that RLAY’s stock grew similarly to ELDN’s over the last 12 months.
RLAY's Price Growth Rating (37) in the null industry is somewhat better than the same rating for ELDN (83) in the Pharmaceuticals Major industry. This means that RLAY’s stock grew somewhat faster than ELDN’s over the last 12 months.
RLAY's P/E Growth Rating (35) in the null industry is somewhat better than the same rating for ELDN (98) in the Pharmaceuticals Major industry. This means that RLAY’s stock grew somewhat faster than ELDN’s over the last 12 months.
| ELDN | RLAY | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 89% | N/A |
| Stochastic ODDS (%) | 1 day ago 89% | 1 day ago 88% |
| Momentum ODDS (%) | N/A | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 87% | 1 day ago 86% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 85% |
| Advances ODDS (%) | 1 day ago 88% | 3 days ago 86% |
| Declines ODDS (%) | 9 days ago 88% | 1 day ago 87% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 86% | 1 day ago 87% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELDN’s FA Score shows that 0 FA rating(s) are green while RLAY’s FA Score has 1 green FA rating(s).
- ELDN’s FA Score: 0 green, 5 red.
- RLAY’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELDN’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).
- ELDN’s TA Score: 5 bullish, 3 bearish.
- RLAY’s TA Score: 4 bullish, 4 bearish.
Price Growth
ELDN (@Biotechnology) experienced а +0.44% price change this week, while RLAY (@Biotechnology) price change was +6.01% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
ELDN is expected to report earnings on Nov 13, 2026.
RLAY is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ELDN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with EDIT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To ELDN | 1D Price Change % | ||
|---|---|---|---|---|
| ELDN | 100% | +1.77% | ||
| EDIT - ELDN | 35% Loosely correlated | -0.80% | ||
| STRO - ELDN | 34% Loosely correlated | -4.63% | ||
| NTLA - ELDN | 34% Loosely correlated | -4.21% | ||
| RLAY - ELDN | 33% Poorly correlated | -0.38% | ||
| DNLI - ELDN | 32% Poorly correlated | -0.11% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LDDR | 75.08 | 0.54 | +0.73% |
| Stone Ridge Trust Stone Ridge 2035 Term Income ETF | |||
| IBIH | 25.28 | 0.14 | +0.58% |
| iShares iBonds Oct 2031 Term TIPS ETF (IBIH) | |||
| PMNV | 26.54 | -0.03 | -0.11% |
| PGIM S&P 500 Max Buffer ETF - November (PMNV) | |||
| GMAY | 43.98 | -0.34 | -0.77% |
| FT Vest U.S. Equity Moderate Buffer ETF - May (GMAY) | |||
| APUE | 47.12 | -0.55 | -1.15% |
| ActivePassive U.S. Equity ETF (APUE) | |||